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Abstract Increased, decreased or normal excitability to
transcranial magnetic stimulation (TMS) has been reported
in the motor (M1) and visual cortices of patients with
migraine. Light deprivation (LD) has been reported to
modulate M1 excitability in control subjects (CS). Still,
effects of LD on M1 excitability compared to exposure to
environmental light exposure (EL) had not been previously
described in patients with migraine (MP). To further our
knowledge about differences between CS and MP,
regarding M1 excitability and effects of LD on M1 excit-
ability, we opted for a novel approach by extending mea-
surement conditions. We measured motor thresholds (MTs)
to TMS, short-interval intracortical inhibition, and ratios
between motor-evoked potential amplitudes and supra-
maximal M responses in MP and CS on two different days,
before and after LD or EL. Motor thresholds significantly
increased in MP in LD and EL sessions, and remained
stable in CS. There were no significant between-group
differences in other measures of TMS. Short-term variation
of MTs was greater in MP compared to CS. Fluctuation in
excitability over hours or days in MP is an issue that, until
now, has been relatively neglected. The results presented
here will help to reconcile conflicting observations.
Keywords Migraine  Magnetic stimulation 
Neurophysiology  Motor physiology  Physiology
Introduction
Abnormal cortical excitability is an intriguing piece in the
puzzle of migraine pathogenesis. While strong data support
increase in activity or excitability in the cerebral cortex
measured in visual and motor areas of patients with
migraine (MP), there is also evidence that decreased
excitability leading to decreased preactivation and lack of
habituation to afferent stimuli is migraine’s biological
signature [1–4]. Inconsistencies between these mixed
results have not yet been resolved.
A widely used, powerful, and non-invasive tool to
evaluate cortical excitability in humans is transcranial
magnetic stimulation (TMS) (for a review, see [5]). In MP,
visual and corticospinal or cortico-cortical excitabilities to
TMS have been found to be increased, decreased, or nor-
mal, compared to control subjects without migraine (CS)
[1–4, 6, 7]. The debate was therefore not settled by these
studies probably because, in all of them, only single mea-
sures of excitability were performed in MP and CS.
Interestingly, variability of visual cortical excitability
measured once a day on different days is greater in MP
than in CS [7, 8]. This finding raises the important point
that increased fluctuation, rather than mere increase or
decrease in excitability, may be a marker of abnormal
neuronal function in migraine. However, whether this
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phenomenon is restricted to the visual cortex in MP, and
whether it occurs within a day or over several days, is
unknown.
In contrast to the conflicting evidence regarding cortical
excitability to TMS, a well-recognized feature in MP is the
abnormal responsiveness to external stimuli such as envi-
ronmental light [9]. It is known that light deprivation (LD)
modulates visual [10, 11] and motor cortex (M1) [12]
excitability to TMS. Effects of LD on M1 excitability in
MP have not been described.
This is the first study to compare variability of motor
cortex excitability within a day and across several days in
MP and CS, before and after LD or exposure to environ-
mental light exposure (EL). We hypothesized that: (1)
variability of excitability would be greater in MP compared
to CS; (2) LD would increase excitability to a greater
extent in MP than in CS.
Methods
Subjects
Twenty-six women participated in the study: 17 MP
(mean age ± standard error (SE), 35.2 ± 2.8 years), 9 CS
(34.1 ± 4.1 years). Inclusion criteria for MP were: diag-
nosis of migraine (with aura, without aura, or chronic)
according to the International Headache Society criteria
[13], and at least one migraine attack in the month before
the experiments.
Exclusion criteria for all subjects were: left-handedness
according to the Oldfield inventory [14]; abnormal brain
magnetic resonance imaging; contraindications to TMS
[15]; psychiatric conditions other than anxiety or depres-
sion; neurological conditions; in the last 4 weeks, use of
prophylactic migraine drugs (beta-blockers, calcium channel
blockers, antidepressants, or antiepileptic drugs), or any drugs
known to interfere in excitability to TMS [16].
Potential CS were excluded if they had a history of any
headache during lifetime that fulfilled criteria for a migraine
attack according to ICH criteria, any primary headache other
than episodic tension-type headache, or any headache in the
month before the experiments. Migraine is more common in
women than in men, so it was not surprising that all MP
volunteers were women [17]. To avoid differences in gender
composition between the groups, male gender was an
exclusion criteria in the CS group. The experimental proto-
col was approved by the ethics committee and conformed to
ethical standards described in the Declaration of Helsinki.
All subjects provided written informed consent.
In MP, migraine history averaged (±SE) 21.1 ± 2.5
years and the mean number (±SE) of days with pain
per month was 13.8 ± 1.6. Median MIDAS (Migraine
Disability Assessment Score) [18] was IV (range I–IV) and
median usual pain intensity (analog score 0–10) was 8 (range
6–10). Ten MP had episodic and seven had chronic migraine
(Table 1). Patient 15 fulfilled IHS criteria for chronic
migraine but had fewer than 15 days of pain in the month
prior to TMS experiments (partial remission).
Experimental design
Every subject participated in two TMS sessions in a
crossover experimental design (Fig. 1). In all experiments,
subjects were set at rest, comfortably seated. Transcranial
magnetic stimulation was performed before and after
30 min of either LD or EL. This LD or EL extent was
chosen because it was reported that 30 min of LD caused
an increase in motor cortex excitability in CS [12].
During LD, after the initial TMS measurements under
standard room lighting conditions (530 lux), ambient lumi-
nance was reduced to a level just sufficient for the investi-
gator to perform TMS; subjects wore opaque goggles and
reported complete absence of perceived light. In EL sessions,
subjects were only exposed to standard room lighting con-
ditions (530 lux). Therefore, LD was the specific interven-
tion and EL, the control condition. In both sessions, subjects
listened to standard songs during the 30 min of LD or EL and
were instructed to remain awake during TMS measurements
with their eyes open [12, 19]. These instructions were
important to avoid sleepiness as the subjects remained with
eyes closed, in a relatively resting condition for the 30-min
period of LD or EL experiments.
The order of the sessions was randomized across subjects.
The maximum interval between experiments was 1 month
and all experiments were performed between 1 p.m. and
6 p.m. There were no significant differences between the CS
and MP groups regarding the intervals between the two TMS
sessions (p = 0.87): 6.8 ± 1.7 days in MP and 6.3 ± 2.2
days in CS. In the MP group, there were no significant dif-
ferences (p = 0.73) in the number of days between the last
migraine attack and the LD (2.9 ± 0 days) or EL
(3.0 ± 1.1 days) sessions. One patient did not recall the
exact date of her last migraine episode before LD and another
one before EL. Patient 16 reported mild, dull headache,
different from migraine, during EL. The pain subsided
spontaneously. Patients 7 and 13 reported headache in both
experimental sessions, patient 9 in the EL session and patient
12 in the LD session. None of the patients reported auras
during or up to 24 h before the experiments.
TMS
Transcranial magnetic stimulation biphasic pulses were
delivered to the ‘‘hot spot’’ of the left M1 for the right
abductor pollicis brevis (APB) through a MC-B70
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figure-of-eight coil (2 9 100 mm, 31kT/s) connected to a
MagPro X100 magnetic stimulator (Alpine Biomedical).
The coil was placed tangentially to the scalp, with the
intersection of both wings at a 45 angle with the midline.
Electromyographic (EMG) activity was recorded from
surface electrodes placed over the APB muscle, the
responses amplified (1,000), filtered (2 Hz–2 kHz), and
recorded on a computerized data acquisition system built
with the LabVIEW graphical programming language
(sampling rate 5 kHz). Its conditional triggering feature
was used to deliver TMS stimuli only when the APB
muscle was relaxed (EMG activity at baseline \50 lV
peak-to-peak amplitude for at least 1 s) [20].
After identification of the APB hot spot, the following
TMS measurements [5] were obtained at baseline and
immediately after LD and EL sessions: (a) Resting motor
threshold (MT), a measure of corticomotor excitability
defined as the minimum TMS intensity (measured to the
nearest 1% of the maximum output of the magnetic stim-
ulator and delivered randomly 5–7 s apart) required to
elicit at least three out of six motor-evoked potentials
(MEP) C50 lV in consecutive trials, as previously repor-
ted [21, 22]. Transcranial magnetic stimulation stimulus
intensities were expressed relative to the MT measured
Table 1 Measures of excitability to transcranial magnetic stimulation in patients with migraine
MP Type of
migraine
MT
Pre-EL
MT
Post-EL
MT
Pre-LD
MT
Post-LD
SICI
Pre-EL
SICI
Post-EL
SICI
Pre-LD
SICI
Post-LD
N Pre-EL N Post-EL N Pre-LD N Post-LD
1 Episodica 45 50 44 46 49.3 29.9 42.6 74.3 18 21 16 14
2 Episodica 36 38 35 34 110.9 61.1 36.1 49.4 21 21 19 19
3 Episodica 28 27 35 34 57.5 53.5 29.6 33.9 25 25 17 19
4 Episodicb 35 41 31 32 11.4 27.2 47.2 21.6 52 31 21 16
5 Episodicb 39 40 42 44 21.6 43.1 59.9 66.1 19 15 64 19
6 Episodicb 36 36 35 36 117.8 209.2 105.0 88.2 15 24 25 21
7 Episodicb 45 50 44 46 147.3 135.3 182.5 141.6 18 25 15 30
8 Episodicb 37 38 40 40 24.0 70.1 20.9 35.7 25 20 17 18
9 Episodicb 63 61 58 58 69.7 65.5 91.7 104.9 23 17 21 23
10 Episodicb 39 41 39 46 9.2 8.3 38.1 8.1 18 25 27 15
11 Chronic 28 31 29 31 72.7 76.09 37.3 21.1 24 15 23 17
12 Chronic 50 50 49 49 28.9 17.7 33.4 33.6 14 13 17 24
13 Chronic 75 75 68 72 31.9 107.4 51.6 51.1 40 22 21 18
14 Chronic 30 33 32 33 57.6 112.2 31.9 129.4 25 25 18 20
15 Chronic 50 55 42 55 10.5 9.5 10.5 2.9 18 20 25 25
16 Chronic 34 37 36 35 99.9 134.3 82.0 86.5 23 14 16 19
17 Chronic 34 33 35 35 11.3 37.3 33.2 92.9 25 20 22 21
Mean 41.4 43.3 40.8 42.7 54.8 70.5 54.9 61.3 23.7 20.8 22.6 19.9
S.E. 2.9 2.8 2.3 2.5 9.8 12.4 9.4 9.5 2.1 1.1 2.6 0.9
Motor thresholds (MT, % of stimulator’s output), short-interval intracortical inhibition (SICI, %), and number of stimuli (N) in determination of MT in
patients with migraine pre- and post-standard room light exposure (EL) and pre- and post-light deprivation (LD)
a With aura
b Without aura
SE standard error
Fig. 1 Experimental paradigm. Visual Analog Mood Scores (VAMS)
and measures of excitability were performed before (left) and after
(right) environmental light exposure (EL, top) and light deprivation
(LD, bottom) sessions in patients with migraine (MP) and in control
subjects (CS). In the EL session, subjects were exposed to ambient
light. In the LD session, goggles were kept in place for 30 min and
until measurements of excitability were finished. After finding the hot
spot to register motor-evoked potentials (MEP) in the right abductor
pollicis brevis muscle, motor threshold (MT), short-interval intracor-
tical inhibition (SICI), MEP amplitudes at intensities of 0.9, 1.1, and
1.3 MT, and amplitudes of supraxamaximal M responses (M) were
evaluated before and after EL or LD. In both sessions, subjects were
instructed to remain at rest with eyes open
J Headache Pain (2012) 13:29–37 31
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from the APB. Numbers of stimuli to determine MT were
recorded for each subject in each condition. (b) Short-
interval intracortical inhibition (SICI) was measured with
paired-pulse TMS. SICI likely reflects intracortical function
in GABAergic inhibitory interneurons [5]. Conditioning
stimulus intensity was set to 80% of the APB MT. The
intensity of the test stimulus was that required to evoke MEPs
of approximately 0.5–1 mV (MEPTS). This procedure was
described by Kujirai in the classical paired-pulse paradigm
[23]. The order of presentation of inhibitory (2 ms) and
control trial (test stimulus alone) intervals was randomized
across subjects. Twelve paired and 12 control trials were
recorded. Results were expressed as average percentages of
MEP amplitudes in conditioning trials and in test trials
(MEPconditioning stimuli ? test stimuli/MEP test stimuli,%).
(c) MEP peak-to-peak amplitudes at intensities of 0.9, 1.1,
and 1.3 MT. The order of stimulus intensities was random-
ized across subjects. Results are expressed relative to the
maximal peripheral M response peak-to-peak amplitudes
(MEP/M, %). M responses were obtained by supramaximal
stimulation of the median nerve at the wrist. MEP amplitudes
were expressed relative to the amplitude of the maximal
peripheral M response. This measurement allows controlling
for differences in muscle bulk and electrode position across
subjects and reflects the extent of activation of the spinal
motor neuron pool of a target muscle, by a single TMS pulse
at a given stimulus intensity. Ten trials were performed for
each stimulation intensity. One CS refused M response
recording and the results from one MP were excluded due to
technical problems (MEPs were not saved).
All experiments were performed at the same phase of
the menstrual cycle, or in active dosage and withdrawal
phases in each subject taking low dosage oral contracep-
tives, because previous studies showed that, even though
MT are unchanged by hormonal levels in both MP and CS,
there are differences in SICI measured in the follicular
phase compared to the luteal phase in CS [24, 25].
Subjective states
To evaluate modulation of subjective states by the experi-
mental interventions, Visual Analog Mood Scale (VAMS) of
Norris translated into Portuguese [26] was evaluated before
and after the LD and EL experimental sessions. VAMS
consists of 16 analog scale items printed in a single page.
Each item is composed of a pair of opposite adjective words,
with a horizontal 100-mm line in between the words. For
each item, subjects were requested to mark a point on the line
with the distance to each word proportional to his/her feel-
ings at that moment. Cluster analysis grouped the items into
four factors: (1) cognitive impairment, composed of the
items quick-witted/mentally slow, proficient/incompetent,
energetic/lethargic, clear-headed/muzzy, gregarious/with-
drawn, well-coordinated/clumsy, and strong/feeble; (2)
anxiety, made of the items calm/excited, relaxed/tense, and
tranquil/troubled; (3) sedation, composed of alert/drowsy
and attentive/dreamy; (4) discomfort, made of interested/
bored, happy/sad, contented/discontented, and amicable/
antagonistic.
Statistical analysis
Data are presented as mean ± SE if normally distributed
and as median (range) otherwise. Ages of CS and MP were
compared with unpaired t tests. Intervals before the last
migraine episode in LD and EL sessions were compared
using Wilcoxon tests.
Motor threshold, short-interval intracortical inhibition,
number of stimuli for MT determination, and VAMS
scores were analyzed with repeated-measures analysis of
variance (ANOVARM) using the factors GROUP (CS and
MP), TIME (pre and post), CONDITION (LD and EL), and
ORDER OF SESSION (first session, LD; or first session,
EL). The factor ‘‘ORDER’’ was included in the model to
evaluate carryover bias in the crossover design used in this
study.
MEP/M ratios were analyzed with repeated-measures
analysis of variance with factors GROUP, TIME, CON-
DITION, STIMULUS INTENSITY (0.9, 1.1, and 1.3rMT),
and ORDER OF SESSION.
Tukey’s post hoc tests with adjusted p values were
performed when appropriate. p values \0.05 were con-
sidered to be statistically significant. SAS 9.1 and SPSS
17.0 were used for statistical analysis.
Results
Measures of cortical excitability
Motor thresholds
Motor threshold results and the number of stimuli given to
each subject are shown in Tables 1 and 2. ANOVARM
revealed significant interactions GROUP 9 TIME [F(1,24) =
6.28; p = 0.02] and GROUP 9 ORDER [F(1,24) = 5.43;
p = 0.03]. There were no significant effects of CONDITION
or interactions between other factors (p [ 0.05).
Post hoc analysis showed that although MTs did not
change significantly in CS (t = 0.46; p = 0.97), they
increased significantly in MP after either LD or EL when
compared with results obtained before these interventions
(t = -3.72; p = 0.0061) (Fig. 2). There were no signifi-
cant effects of ORDER revealed by post hoc Tukey’s tests
(p = 0.085 for CS and p = 0.964 for MP).
32 J Headache Pain (2012) 13:29–37
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Next, we evaluated whether the number of stimuli for MT
determination was comparable in the LD and EL sessions. No
significant effects of GROUP, TIME, CONDITION, ORDER,
or interactions between these factors (p [0.05) were found.
These results demonstrate that MTs were less stable in MP
than in CS over a short period of time, and that LD or EL
conditions did not affect this measurement in both groups,
regardless of whether LD or EL was the first experimental
session to be performed.
Short-interval intracortical inhibition
Short-interval intracortical inhibition results are shown in
Tables 1 and 2. ANOVARM revealed significant interactions
GROUP 9 CONDITION 9 ORDER [F(1,24) = 5.41; p =
0.03)] and GROUP 9 TIME [(F(1,24) = 6.23; p = 0.021)],
while post hoc analysis did not show any significant effects
(p [ 0.05 for all comparisons).
MEP/M ratios
There were no significant effects of GROUP, TIME, or
ORDER in MEP/M ratios, or interactions between any of
these factors (p [ 0.05). However, a significant effect was
found for STIMULUS INTENSITY [F(2,44) = 134.6;
p B 0.001]. As expected, MEP/M ratios increased at
greater stimulus intensities in both groups (p \ 0.001 for
all comparisons). In addition, there was a significant effect
of CONDITION [F(1,23) = 5.75; p = 0.026]. Overall,
MEP/M ratios were significantly higher in the EL session
compared to the LD session (t = 2.08; p = 0.049).
These results are shown in Supplementary Table 1.
Subjective states
Supplementary Tables 2 and 3 show VAMS results.
ANOVARM revealed significant effects of TIME
[F(1,24) = 4.48; p = 0.046] and CONDITION [F(1,24) =
4.46; p = 0.046] regarding VAMS scores for cognitive
impairment. In both groups, scores increased after either
LD or EL sessions and were lower in EL compared to LD
sessions.
ANOVARM revealed a significant interaction CONDI-
TION 9 TIME [F(1,24) = 6.3; p = 0.019] regarding anxi-
ety scores. There were no significant effects of GROUP,
ORDER, or other interactions between any of the factors
analyzed (p [ 0.05). Differences in anxiety scores were not
Table 2 Measures of excitability to transcranial magnetic stimulation in control subjects
CS MT
Pre-EL
MT
Post-EL
MT
Pre-LD
MT
Post-LD
SICI
Pre-EL
SICI
Post-EL
SICI
Pre-LD
SICI
Post-LD
N
Pre-EL
N
Pre-EL
N
Pre-LD
N
Post-LD
1 33 32 29 31 40.1 23.8 55.1 44.5 44 26 19 17
2 36 34 33 36 54.9 28.0 51.1 36.2 17 41 24 16
3 56 51 58 58 23.8 7.5 15.0 5.3 22 19 13 13
4 57 58 56 56 67.1 38.0 14.9 36.5 20 43 50 18
5 39 40 41 43 145.9 113.9 86.5 86.6 24 18 14 20
6 34 34 31 35 38.3 28.3 63.9 52.7 21 21 21 51
7 45 42 51 43 106.8 46.55 194.2 120.8 29 14 16 17
8 30 30 30 28 69.5 65.8 47.2 40.5 20 17 20 25
9 31 31 31 31 33.8 32.9 41.0 46.1 32 31 17 17
Mean 40.1 39.1 40.0 40.1 64.5 42.8 63.2 52.1 25.4 25.6 21.6 21.6
SE 3.2 3.1 3.7 3.4 12.4 9.8 17.0 10.4 2.6 3.3 3.5 3.6
Motor thresholds (MT, % of stimulator’s output), short-interval intracortical inhibition (SICI, %), and number of stimuli (N) in determination of
MT in control subjects pre- and post-standard room light exposure (EL) and pre- and post-light deprivation (LD)
SE standard error
Fig. 2 Changes in motor thresholds. Absolute differences between
motor thresholds (in percentage of stimulator’s output) achieved for the
light exposure (EL) session (Post-EL–Pre-EL, white columns) and for
light deprivation (LD) session (Post-LD–Pre-LD, black columns) in
patients with migraine (MP) and control subjects (CS). *p \ 0.05. NS
nonsignificant
J Headache Pain (2012) 13:29–37 33
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significant according to post hoc analysis: pre-EL 9 post-
EL, p = 0.196; pre-LD 9 post-LD, p = 0.136; pre-LD 9
pre-EL, p = 0.354; post-LD 9 post-EL, p = 0.078.
There were no significant effects or interactions
regarding VAMS scores for sedation or discomfort
(p [ 0.05).
In summary, cognitive impairment was greater at the
end of the experimental sessions in both groups, although it
was more prominent in the LD than in the EL sessions.
There were no measurable changes in anxiety, sedation, or
discomfort between groups, across time or conditions.
Discussion
The main result of this study was that MT increased sig-
nificantly within a short period of time (less than 2 h) in
MP, but remained stable in CS. This change cannot be
attributed to differences in muscle relaxation, because the
computer-controlled system used to trigger the magnetic
stimulator insured that TMS pulses were administered only
at rest, during all MT measurements. Furthermore, there
were no significant between-group differences regarding
cognitive impairment, anxiety, sedation, or discomfort. The
lack of significant differences in MT in the CS group
reported here is in agreement with previous reports
involving measurements repeated seven times within 10 h
[27] and once daily on three different days [27–29], indi-
cating the stability of MT in CS.
Repetitive testing was crucial to observe this MT vari-
ability and may explain discrepant results in previous reports
[1–4]. It is reasonable to think that if MT is less stable in MP
than in CS, differences between groups may or may not arise
depending on when the punctual measurements are col-
lected. Our results indicate that controversies about excit-
ability to TMS in MP may partially be due to this factor.
Baseline MTs, measured before LD and EL on different
days did not significantly differ in MP in our study, in
contrast to phosphene thresholds that were shown to vary
significantly more in MP than CS across days [7, 8]. One
plausible explanation is that fluctuation in visual cortex
excitability does not necessarily parallel fluctuation in M1
excitability. Phosphene thresholds measured once a day
were shown to increase, 1–2 days before migraine attacks
in children, while MT measured once a day did not signi-
ficantly change in the interictal period [6]. Resting MT and
phosphene thresholds were found not to correlate signifi-
cantly in healthy subjects in a number of studies [30–33]
even though a significant correlation was found between
active MT (measured during voluntary muscle contraction)
and phosphene thresholds when similar thresholding proce-
dures were employed for both measurements of excitability
[34].
Also, phosphene threshold is known to be more variable
than MT across and within subjects [7, 8, 33] and depends
on subjective responses, while MT relies on objective
determination of MEPs. Finally, the use of different types
of stimulators and coils limit result comparability between
our results and those of studies that evaluated phosphene
thresholds in MP and CS.
The magnitude of change in MT in the MP group was
small (mean around 2%) but significant. MT is a fairly stable
TMS measure that can change significantly after brain
lesions, such as stroke or amyotrophic lateral sclerosis [35,
36], or administration of drugs that interfere on ionic chan-
nels or on NMDA receptors [16]. On average, MT increases
in 2–10% after administration of antagonists of sodium and
calcium channels [16, 37–41] and decreases in 2.7–6.7%
after administration of the NMDA antagonist ketamine [42].
Therefore, the magnitude of change in MT even after
administration of these drugs is relatively small. Considering
that no overt structural lesions and only subtle changes in
brain excitability would be expected in migraine, we obvi-
ously did not anticipate large shifts in MT in MP.
The significant increase in MT observed over a short
period of time in MP may reflect abnormal function of
ionic channels [1, 3], because MT can be significantly
increased by antagonists of sodium and calcium channels
[16] and for this reason is considered a marker of ion
channel excitability in the motor cortex. Furthermore,
mutations of neuronal ionic channels have been identified
in rare, familial forms of migraine [43–45]. Neurons with
these mutations can be hypoexcitable and hyperexcitable at
different points in time, i.e., their excitability is more
variable than in non-mutated neurons [46]. Hence,
increased variability in neuronal excitability due to
abnormal function of ionic channels is a candidate expla-
nation to our findings of greater drifts in MT in MP,
compared to CS.
Motor thresholds depend not only on the activity of ion
channels of motor cortical neurons [16, 27], but is also
influenced by other factors: corticospinal fiber orientation,
distance between the coil and the motor cortex, technique
of measurement (coil positioning, type of coil or magnetic
stimulator), excitability of spinal motor neurons, and pos-
sibly by attention, hormonal fluctuations, and fatigue. None
of these other factors explain our findings.
First, within-subject comparisons were performed in MT
measurements and, therefore, corticospinal fiber orientation
was constant. Second, stimulation technique, including the
number of stimuli for MT determination, was comparable in
all TMS sessions. Although we did not use neuronavigation,
it is unlikely that such an approach would have provided a
different explanation because a previous report demon-
strated no significant differences in MT measured with or
without neuronavigation [47]. Third, all experiments were
34 J Headache Pain (2012) 13:29–37
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performed in the afternoon and in the same phase of the
menstrual cycle in each participant, and subjective states were
comparable between the two MP and CS groups. Fourth, no
between-group differences were found in M responses (data
not shown), arguing against spinal mechanisms.
In contrast with MT results, there were no significant
differences between groups with regard to SICI or MEP/M
ratios. MEP/M ratios were significantly lower under a
condition of less cognitive demand (rest in the dark in the
LD session), consistent with previous reports [19, 48]. A
limitation to interpretation of these findings is the extreme
heterogeneity in SICI and MEP/M ratios within and across
subjects. This was not unexpected given the reports about
variability of these measures in CS [10, 19, 49].
Motor thresholds were reported to remain unchanged
while MEP amplitudes were reported to increase and SICI
to decrease after 30 min of LD compared to baseline EL
measured in a different experimental session in CS [12]. In
contrast, LD had no significant effects on SICI or on MEP/
M ratios in CS or in MP in our study. The reason behind
this discrepancy between studies is likely the difference in
experimental designs: measurements were performed once
in each session in the study of Leon-Sarmiento et al. [12],
at baseline in the EL session and after 30 min of LD in the
LD session. In our study, CS and MP remained at rest for
30 min during exposure to environmental light in the EL
session, and without exposure to light in the LD session.
Measurements were performed before and after LD and
EL. Rest influences baseline activity in the brain. The
magnitude of the ‘‘rest’’ condition may have exceeded
effects of LD on MT, therefore obscuring any possible
effects of this intervention compared to EL.
Another question that arises from our research is whether
there is a correlation between the degree of fluctuation in
excitability and clinical features (number, duration, severity
of attacks, use of prophylactic drugs, gender, and pain during
TMS). Most studies on single measurements of MT excluded
data from patients having migraine attacks at intervals
ranging from 1 week to 24 h before and/or after experi-
ments. This was based on pseudo-normalization of neuro-
physiological measures performed with various techniques
other than TMS [1–4]. However, there is no demonstration
that results of these tests mirror excitability measured with
TMS. Furthermore, the hypothesis that migraine attacks
influence MT failed to be confirmed in children [6] and has
not been formally tested in adults. Future studies should
include greater sample sizes, provide detailed information of
migraine attacks for prolonged periods, and perform more
than one MT measurement, within a day and across days.
One exciting, possible application of TMS in a paroxys-
mal disorder such as migraine is to define surrogate end
points for responsiveness to specific therapeutic interven-
tions. In patients with epilepsy, seizure control after 1 year of
treatment with antiepileptic drugs can be predicted from
early increase in MT and intracortical inhibition measured
with TMS after several weeks of treatment [50]. It is possible
that change or rate of change in MT may be useful markers to
predict responsiveness of MP to pharmacological or non-
pharmacological interventions. Moreover, TMS itself has
been suggested to be a potential novel non-pharmacological
intervention to treat MP, due to beneficial effects reported
after single-pulse stimulation of the visual cortex in patients
with migraine with aura [51, 52]. If TMS is to be used to
predict clinical improvements, then MT and fluctuation in
MT are candidate measurements. More studies are necessary
to define whether TMS can be an adjuvant tool to stratify
patients for specific therapeutic strategies.
Although our study encompassed patients with
migraine without aura, with aura, and chronic migraine,
we were able to find significant differences between M1
excitability in MP, compared to CS. Whether variability
in MT differs in different types of migraine or according
to severity of this condition is a matter to be addressed
in future studies. In addition, whether it predisposes to
migraine attacks or is a consequence of them remains a
difficult question.
The results presented here show for the first time that
fluctuation in MT is greater in MP compared to CS.
Fluctuation in excitability over hours or days in MP is an
issue that, until now, has been relatively neglected and is
important to understanding contradictory findings of pre-
vious studies that performed single measures of excitabil-
ity. Many reasons may underlie the stability of electric
activity in cortical neurons, such as the types, quantity, and
activity of ionic channels and the relative strengths of
inhibitory and excitatory synaptic inputs [53]. Adding
fluctuation in cortical excitability to the complex equation
of brain electrical dynamics in migraine will reconcile
conflicting results, which may be useful to enlighten the
pathogenesis underlying this condition.
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